Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHARM: CHG Bathing in Neonates
NCT06590675Terminated
- Sponsor
- University of Pennsylvania
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine in neonatal sepsis and bacterial infection (4 arms), sponsored by University of Pennsylvania. Primary endpoints: Safety of locally prepared 1% and 2% chlorhexidine gluconate (CHG) cleansing: Skin integrity and Safety of locally prepared 1% and 2% CHG cleansing: Systemic responses. Started Feb 2025; status: terminated.
02
Drugs
chlorhexidine
03
Conditions
neonatal sepsisbacterial infection
Beyond the preview
Go deeper on NCT06590675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590675.